The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

BACKGROUND: The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of patients likely to receive treatment in Europe has not been quantified. The aim of this study was to forecast the annual number of patients with squamous and non-squamous advanced NSCLC li...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, David, O’Day, Ken, Hertel, Nadine, Penrod, John R., Manley Daumont, Melinda, Lees, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257974/
https://www.ncbi.nlm.nih.gov/pubmed/30477516
http://dx.doi.org/10.1186/s12963-018-0174-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257974/
https://www.ncbi.nlm.nih.gov/pubmed/30477516
http://dx.doi.org/10.1186/s12963-018-0174-4

Ejemplares similares